Document text
Principal Investigator: Elodie Ghedin
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2023
Award: $180,957
Funding agency: National Institute of Allergy and Infectious Diseases
The major aspects of this project involve characterizing SARS-CoV-2 genetic diversity and microbial communities in the respiratory tract during infection. This involves analyzing samples from COVID-19 positive subjects, and from model animal infections. As part of this project we tackle different types of studies that include:
(a) Molecular epidemiology
(b) Virus evolution and genetic diversity within infected hosts
(c) Respiratory tract microbiome profiles and host response
(a) Molecular epidemiology
Whole genome sequencing of SARS-CoV-2 has become crucial for epidemiology studies and to determine how the virus sweeps through various populations, with the transmission potential of new emerging variants. We currently have 3 ongoing genomic epidemiology studies: The first 2 studies are in collaboration with clinical and public health teams in the Dominican Republic and Haiti. For the DR/Haiti study, we are combining phylogenetics with travel history data, and are using the viral diversity information to determine the number of independent introductions into each of these countries that shutdown their borders and airports early in the pandemic. From a public health perspective, it will also enable an evaluation of how efficient border closings are in limiting the introduction of new variants. The Caribbean is a populous region (>40 million people in the island states) at the crossroads of many trade routes and visited by tourists from around the world, yet is drastically undersampled relative to Europe and North America. We analyzed samples from Haiti in Spring 2020, making this the biggest collection from a single Caribbean island in this time period studied so far. Although the number of specimens sequenced in this study nearly doubles the number of specimens available for the early pandemic in the region, the absolute number of samples is small compared to the scale of sequencing in other parts of the world. This increase is nevertheless sufficient to demonstrate that covid-19 was spreading among Caribbean islands in early 2020 and to show that at least one lineage was possibly introduced from the Caribbean into North America, where it sustained community submission over a period of several months. These 2 studies will be submitted for publication in the fall. The third study is a collaboration with Dr. Marcel Tongo in Cameroon with samples from 2020, 2021, and 2022 to determine the diversity of what was circulating.
(b) Virus evolution and genetic diversity within infected hosts
While identification of new clades and lineages, and the associated viral consensus changes help in tracking spread of the virus, few studies have been done on the minority variants present in infected individuals. These minority variants could be seeding the emergence of new clades, thus identifying them early is of relevance for preparedness and to track transmission events. In an ongoing collaboration with Dr. James Musser (Houston Methodist), we used deep sequences of thousands of SARS-CoV-2 clinical samples to explore within-host diversity of the virus from a high-throughput viral surveillance program associated with a large hospital system. This project has required a complete revision of how we tackle opportunistic datasets for deep sequencing analyses and the identification of all the artifacts that can be introduced. We had initially submitted this manuscript for publication but in response to reviewer comments have revisited our approach. The identification of low-level variants, when effectively distinguished from sequencing artifacts, can help shed light on intrahost viral evolution. In our retrospective genomic observational study, we analyzed 35,000 clinical samples from COVID-19 patients in the Houston Methodist Hospital System collected between December 2020 and January 2022. While using intrahost single-nucleotide variants (iSNVs), we investigated the level of molecular artifacts and systematically filtered them using codon positional biases. We introduced a quantitative estimate of viral titers using sequencing coverage metrics to control for its confounding effect on iSNVs levels. Using the >10,000 higher quality samples and rich clinical metadata, we found that clinical factors, such as vaccination and monoclonal antibody use, did not affect selection at the minor variants but did at the de novo major variants. Lastly, we found that iSNVs foreshadowed mutations in Spike that would later appear in the pandemic.
In a collaborative study with Dr. Mirella Salvatore (Weill Cornell), we are currently analyzing the within-host evolution of SARS-CoV-2 in immunocompromised patients with mostly B cell defects. Persistent viral replication occurs in immunosuppressed patients with SARS-CoV-2 and viral persistence in this setting has raised concern for viral evolution and the emergence of variants. We are also analyzing the effects of therapies on viruse evolution in these protracted infections. In another collaborative study, with Dr. Daniel Chertow (VRC/NIAID), we are determining the diversity of SARS-CoV-2 across tissues from an autopsy case from a patient with an inborn genetic disease that leads to immunocompromise. For both studies we have been resequencing all the samples on a different platform (PacBio) in collaboration with Dr. Melissa Smith (University of Louisville). In both of these studies, SARS-CoV-2 mutations of interest were identified and the isolated viruses are being tested in functional assays in the labs of Dr. Diego Diehl (Cornell), and Dr. Mehul Suthar (Emory)..
Since immunocompromise has become of particular interest as it allows to see what genetic space the virus can explore, we are also finalizing a study with Dr. Mehul Suthar (Emory) who collected virus from nasal turbinates of CD4CD8 T cell depleted mice.
(c) Respiratory tract microbiome profiles and host response
In our first study of the airway microbiome of COVID19 patients, we focused on the metagenomic and metatranscriptomic analysis of cross-sectional BAL samples collected from mechanically ventilated patients during the first wave of the pandemic in NYC. However, while these patients all had severe disease requiring intubation, the mortality rate was much lower in this cohort because only stable patients could undergo bronchoscopy. In a follow-up study, we are analyzing longitudinal samples from the first wave and from the second wave with approximately 70 patients for which 1-5 samples were collected up to 6 weeks follow-up. Samples from the first wave are from BAL, while samples from the 2nd wave are primarily tracheal aspirates, which allows us to analyze the microbiome for critically ill patients who could not undergo bronchoscopies. From the same cohort, we are doing a parallel study on patients who are immunocompromised. This cohort has rich metadata on therapeutic regimens and symptoms.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Active Follow-up><Animal Model><Animal Models and Related Studies><Animals><Artifacts><Assay><Autopsy><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><Bioassay><Biologic Assays><Biological Assay><Body Tissues><Bronchoscopy><COVID infected patient><COVID patient><COVID positive patient><COVID-19><COVID-19 infected patient><COVID-19 patient><COVID-19 positive><COVID-19 positive patient><COVID-19 positivity><COVID-19 virus><COVID19><COVID19 patient><COVID19 positive><COVID19 positive patient><COVID19 positivity><COVID19 virus><CV-19><CV19><Cameroon><Caribbean><Caribbean Islands><Caribbean Sea Region><Caribbean region><Clinical><Clinical Treatment Moab><CoV-2><CoV2><Codon><Codon Nucleotides><Collaborations><Collection><Comment><Commentary><Communities><Conchae Nasales><Consensus><Country><Critical Illness><Critically Ill><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><DNA Resequencing><Data><Data Set><Defect><Disease><Disease Frequency Surveys><Disorder><Dominican Republic><Editorial Comment><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Europe><Evaluation><Event><Evolution><Follow-Up Studies><Followup Studies><Functional Metagenomics><Genetic><Genetic Alteration><Genetic Change><Genetic Diversity><Genetic Variation><Genetic defect><Genomics><Goals><Groups at risk><Haiti><Hereditary Disease><History><Hospitals><Host Factor><Host Factor Protein><Human><Immune response><Immunocompromised><Immunocompromised Host><Immunocompromised Patient><Immunological response><Immunosuppressed Host><Inborn Genetic Diseases><Individual><Infection><Inherited disorder><Integration Host Factors><Intubation><Island><Manuscripts><Mechanical ventilation><Metadata><Metagenomics><Methodist Church><Methodists><Mice><Mice Mammals><Minor><Minority><Modern Man><Molecular><Molecular Epidemiology><Monoclonal Antibodies><Morphologic artifacts><Murine><Mus><Mutation><NIAID><Nasal><Nasal Passages Nose><Nasal turbinate bone structure><National Institute of Allergy and Infectious Disease><North America><Nose><Obesity><Observation research><Observation study><Observational Study><Observational research><Pathogenesis><Patients><People at risk><Persons><Persons at risk><Phylogenetic Analysis><Phylogenetics><Population><Populations at Risk><Preparedness><Public Health><Publications><Published Comment><Pulmonary Body System><Pulmonary Organ System><Readiness><Recording of previous events><Regimen><Research Design><Research Specimen><Resequencing><Respiratory System><Respiratory System, Nose, Nasal Passages><Respiratory Tracts><Respiratory tract structure><Route><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 infected patient><SARS-CoV-2 patient><SARS-CoV-2 positive><SARS-CoV-2 positive patient><SARS-CoV-2 positivity><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Scientific Publication><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 positive><Severe acute respiratory syndrome coronavirus 2 positivity><Severe acute respiratory syndrome related corona virus 2><Severity of illness><Single Base Polymorphism><Single Nucleotide Polymorphism><Specimen><Study Type><Surveillance Program><Symptoms><System><T-Cell Depletion><T-cell depletion therapy><T-lymphocyte depletion therapy><Testing><Therapeutic><Time><Tissues><Trachea><Trachea Proper><Transmission><Travel><Turbinates><Universities><Vaccination><Variant><Variation><Viewpoint><Viral><Virus><Virus Replication><Visit><West Indies><West Indies Region><Wuhan coronavirus><active followup><adiposity><airway microbiome><analyze microbiome><analyzing longitudinal><aspirate><cohort><community microbes><corona virus disease 2019><coronavirus disease 2019><coronavirus disease 2019 infected patient><coronavirus disease 2019 patient><coronavirus disease 2019 positive><coronavirus disease 2019 positive patient><coronavirus disease 2019 positivity><coronavirus disease 2019 virus><coronavirus disease infected patient><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease-19><coronavirus disease-19 patient><coronavirus disease-19 virus><coronavirus infectious disease-19><coronavirus patient><corpulence><deep sequencing><disease severity><entire genome><epidemiologic investigation><epidemiology study><falls><follow up><follow-up><followed up><followup><full genome><genome mutation><genome sequencing><genomic epidemiology><hCoV19><hereditary disorder><heritable disorder><histories><host response><immune system response><immunoresponse><immunosuppressed patient><inborn error><inherited diseases><inherited genetic disease><inherited genetic disorder><interest><longitudinal analysis><mAbs><mechanical respiratory assist><mechanically ventilated><meta data><metatranscriptomics><microbial community><microbiome analysis><model of animal><monoclonal Abs><mortality><nCoV2><necropsy><novel><pandemic><pandemic disease><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><postmortem><pressure><respiratory microbiome><respiratory tract microbiome><response><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><single nucleotide variant><study design><transmission process><viral multiplication><viral replication><virus multiplication><whole genome><windpipe>